share_log

HC Wainwright & Co. Downgrades Landos Biopharma to Neutral, Lowers Price Target to $20.42

Moomoo 24/7 ·  Apr 1 07:12

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Landos Biopharma (NASDAQ:LABP) from Buy to Neutral and lowers the price target from $50 to $20.42.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment